Thread by @JohnM_AIM

#OPTI notes
Technology:
- Next generation Probiotics
- Gut health/Weight Mgmt
- Microbiome modulators
- Next generation zero cal Sugar replacement
- 25% stake in SBTX worth c.£13m (Skin Microbiome therapies)

1

Opti
Slimbiome weight mgmt:
-Very few weight mgmt products on market with EFSA approval
-Partner with Holland&Barrett to create Slimbiome
-scientific studies show Slimbiome increases gut Microbiome diversity
-Scientific studies show change eat habits from sweet & fatty foods

2

OPTI Business model
-predominantly B2B business model building a Global network of partners across the supply chain (manufacture formulation, distribution and retailers) to commercialise their products

- enables OPTI to scale the business for global reach at low

3

#OPTI Summary
-Strong patent position across products
- Built Global supply chain with dozens of partners
-Low cost business model
-commercialising their highly disruptive Sweetbiotix & Microbiome modulator products (could be a game-changers)

4

#OPTI
- on the cusp of Profitability
- Nasdaq listing in 2021
- Holds 25% stake in #SBTX
- CEO hold 11% so has skin in game
- appoint Chris Brimsmead former President of AZ UK
-new broker will help see SBTX

5

Also #OPTI recently announced that its has reached an agreement with Fondazione Edmund Mach to jointly fund and carry out a research project examining the role of its microbiome products to improve sleep, stress, and anxiety - sounds very interesting to me.

Why Microbiome important #opti

https://twitter.com/LEMMINGINVESTOR/status/1353719337199300622?s=19

nutraceuticalbusinessreview.com/news/article_p…

A massive thanks to @online_antz for sharing his insight on #opti.